|
CPT1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.881760E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.503900E-02 |
| Normal-vs-Stage2 |
2.996400E-02 |
| Normal-vs-Stage3 |
1.425850E-01 |
| Normal-vs-Stage4 |
9.573700E-02 |
| Stage1-vs-Stage2 |
1.177590E-01 |
| Stage1-vs-Stage3 |
5.199000E-01 |
| Stage1-vs-Stage4 |
8.988200E-01 |
| Stage2-vs-Stage3 |
7.366400E-02 |
| Stage2-vs-Stage4 |
1.097970E-01 |
| Stage3-vs-Stage4 |
6.371800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.981300E-03 |
| Normal-vs-AfricanAmerican |
4.180800E-03 |
| Normal-vs-Asian |
7.135200E-01 |
| Caucasian-vs-AfricanAmerican |
3.029400E-01 |
| Caucasian-vs-Asian |
8.062400E-01 |
| AfricanAmerican-vs-Asian |
4.079800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.402100E-03 |
| Normal-vs-Female |
3.533800E-02 |
| Male-vs-Female |
6.669400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.501800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.382800E-03 |
| Normal-vs-Age(61-80Yrs) |
6.120300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.595900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.728000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.982000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.278200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.398780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.693400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.977400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.120000E-01 |
| Normal-vs-Grade 2 |
9.978000E-02 |
| Normal-vs-Grade 3 |
1.428300E-02 |
| Normal-vs-Grade 4 |
4.244800E-01 |
| Grade 1-vs-Grade 2 |
6.761400E-01 |
| Grade 1-vs-Grade 3 |
8.038800E-01 |
| Grade 1-vs-Grade 4 |
5.889200E-01 |
| Grade 2-vs-Grade 3 |
3.191800E-01 |
| Grade 2-vs-Grade 4 |
6.535200E-01 |
| Grade 3-vs-Grade 4 |
2.021200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.882000E-01 |
| Normal-vs-ccB subtype |
6.738100E-03 |
| ccA subtype-vs-ccB subtype |
2.202300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.424700E-03 |
| Normal-vs-N1 |
3.510800E-01 |
| N0-vs-N1 |
4.708000E-01 |
|
|
